Who owns Immunovant, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of IMVT from SEC Form 13F filings across 227 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 227 institutions disclosed 110.4M shares of Immunovant, Inc. worth $4.25B — about 53.7% of shares outstanding; the largest disclosed holder is FMR LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
227
13F holders
$4.25B
value, 2026 filers
53.7%
of shares outstanding (110.4M sh)
38
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of IMVT's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | FMR LLC | 16.2M | $623.7M | 0.0% | 7.9% | -4.5% |
| 2 | Deep Track Capital, LP | 9.3M | $359.9M | 5.2% | 4.5% | -19.0% |
| 3 | BlackRock, Inc. | 7.2M | $276.7M | 0.0% | 3.5% | +9.2% |
| 4 | FARALLON CAPITAL MANAGEMENT, L.L.C. | 5.8M | $223.7M | 1.0% | 2.8% | +275.5% |
| 5 | BAKER BROS. ADVISORS LP | 5.4M | $209.4M | 1.0% | 2.6% | -0.4% |
| 6 | STATE STREET CORP | 4.6M | $177.9M | 0.0% | 2.2% | +1.7% |
| 7 | MORGAN STANLEY | 4.5M | $174.7M | 0.0% | 2.2% | +17.0% |
| 8 | TCG Crossover Management, LLC | 4.5M | $171.8M | 4.1% | 2.2% | 0.0% |
| 9 | VANGUARD PORTFOLIO MANAGEMENT LLC | 3.9M | $150.7M | 0.0% | 1.9% | +5.5% |
| 10 | VANGUARD CAPITAL MANAGEMENT LLC | 3.6M | $140.2M | 0.0% | 1.8% | +0.5% |
| 11 | JENNISON ASSOCIATES LLC | 3.3M | $127.5M | 0.1% | 1.6% | +3.6% |
| 12 | RTW INVESTMENTS, LP | 3.2M | $122.4M | 1.0% | 1.5% | 0.0% |
| 13 | Two Seas Capital LP | 3.1M | $121.3M | 2.4% | 1.5% | -1.7% |
| 14 | ADAR1 Capital Management, LLC | 2.3M | $89.8M | 4.1% | 1.1% | -13.0% |
| 15 | GEODE CAPITAL MANAGEMENT, LLC | 2.2M | $86.1M | 0.0% | 1.1% | +6.8% |
| 16 | T. Rowe Price Investment Management, Inc. | 2.2M | $85.6M | 0.1% | 1.1% | -38.5% |
| 17 | Woodline Partners LP | 2.0M | $76.1M | 0.2% | 1% | 0.0% |
| 18 | PRICE T ROWE ASSOCIATES INC /MD/ | 1.8M | $70.5M | 0.0% | 0.9% | +438.6% |
| 19 | GOLDMAN SACHS GROUP INC | 1.8M | $67.5M | 0.0% | 0.9% | -1.9% |
| 20 | ARMISTICE CAPITAL, LLC | 1.7M | $66.9M | 0.8% | 0.8% | -51.3% |
| 21 | Alpine Global Management, LLC | 1.4M | $53.0M | 8.6% | 0.7% | -47.9% |
| 22 | PERCEPTIVE ADVISORS LLC | 1.4M | $52.3M | 0.8% | 0.7% | -15.0% |
| 23 | D. E. Shaw & Co., Inc.NEW | 1.2M | $47.8M | 0.0% | 0.6% | new |
| 24 | BANK OF AMERICA CORP /DE/ | 1.2M | $45.5M | 0.0% | 0.6% | +32.2% |
| 25 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1.0M | $39.4M | 0.0% | 0.5% | +65.5% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.